Skip to main content

Galante Joseph C's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Oct 1, 2021

Accession no.
0001209191-21-058530
Filed
Oct 1, 2021
Trade date
Sep 1-30, 2021
Filing delay
30 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $8.44K. It was filed 30 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Galante Joseph CCIK 0001632384Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 1, 2021Common StockPPurchaseAcquired+142$2.88+$408.9637,955Direct
Sep 2, 2021Common StockPPurchaseAcquired+142$2.88+$408.9638,097Direct
Sep 3, 2021Common StockPPurchaseAcquired+142$2.85+$404.738,239Direct
Sep 7, 2021Common StockPPurchaseAcquired+142$2.79+$396.1838,381Direct
Sep 8, 2021Common StockPPurchaseAcquired+142$2.89+$410.3838,523Direct
Sep 9, 2021Common StockPPurchaseAcquired+142$2.77+$393.3438,665Direct
Sep 10, 2021Common StockPPurchaseAcquired+142$2.78+$394.7638,807Direct
Sep 13, 2021Common StockPPurchaseAcquired+142$2.96+$420.3238,949Direct
Sep 14, 2021Common StockPPurchaseAcquired+142$3.02+$428.8439,091Direct
Sep 15, 2021Common StockPPurchaseAcquired+142$2.86+$406.1239,233Direct
Sep 16, 2021Common StockPPurchaseAcquired+142$2.91+$413.2239,375Direct
Sep 17, 2021Common StockPPurchaseAcquired+142$2.85+$404.739,517Direct
Sep 20, 2021Common StockPPurchaseAcquired+142$2.82+$400.4439,659Direct
Sep 21, 2021Common StockPPurchaseAcquired+142$2.81+$399.0239,801Direct
Sep 22, 2021Common StockPPurchaseAcquired+142$2.76+$391.9239,943Direct
Sep 23, 2021Common StockPPurchaseAcquired+142$2.75+$390.540,085Direct
Sep 24, 2021Common StockPPurchaseAcquired+142$2.74+$389.0840,227Direct
Sep 27, 2021Common StockPPurchaseAcquired+142$2.79+$396.1840,369Direct
Sep 28, 2021Common StockPPurchaseAcquired+142$2.76+$391.9240,511Direct
Sep 29, 2021Common StockPPurchaseAcquired+142$2.82+$400.4440,653Direct
Sep 30, 2021Common StockPPurchaseAcquired+142$2.72+$386.2440,795Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)